MMI: Immunoassay Method, Troponin Subunit
What it covers
A creatine phosphokinase/creatine kinase or isoenzymes test system is a device intended to measure the activity of the enzyme creatine phosphokinase or its isoenzymes (a group of enzymes with similar biological activity) in plasma and serum. Measurements of creatine phosphokinase and its isoenzymes are used in the diagnosis and treatment of myocardial infarction and muscle diseases such as progressive, Duchenne-type muscular dystrophy.
The identification in 21 CFR 862.1215, creatine phosphokinase/creatine kinase or isoenzymes test system. FDA gives MMI no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K253051 | i-STAT hs-TnI cartridge with the i-STAT Alinity System | Abbott Point of Care, Inc. | Jun 11, 2026 | Traditional |
| K252393 | VITROS Immunodiagnostic Products hs Troponin I Reagent Pack | Ortho-Clinical Diagnostics, Inc. | Oct 29, 2025 | Traditional |
| K243483 | Access hsTnI | Beckman Coulter, Inc. | Aug 1, 2025 | Traditional |
| K242870 | Access hsTnI | Beckman Coulter, Inc. | Jun 16, 2025 | Traditional |
| K240984 | i-STAT hs-TnI cartridge with the i-STAT 1 System | Abbott Point of Care, Inc. | Jan 3, 2025 | Traditional |
| K241165 | Atellica® IM High-Sensitivity Troponin I (TnIH) | Siemens Healthcare Diagnostics, Inc. | Jul 25, 2024 | Traditional |
| K231974 | PATHFAST®hs-cTnI-II | Phc Corporation | Mar 20, 2024 | Traditional |
| K222881 | Access hsTnI | Beckman Coulter, Inc. | Dec 18, 2023 | Traditional |
| K230648 | Access hsTnI | Beckman Coulter, Inc. | Dec 4, 2023 | Traditional |
| K230994 | Alinity i STAT High Sensitivity Troponin-I | Abbott Laboratories Diagnostics Division | May 4, 2023 | Special |
Clearances by year
23 MMI 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 262 |
| 2025 | 4 | 266 |
| 2024 | 2 | 176 |
| 2023 | 3 | 270 |
| 2022 | 1 | 625 |
| 2021 | 1 | 477 |
| 2019 | 3 | 88 |
| 2018 | 4 | 344 |
| 2017 | 1 | 93 |
| 2013 | 2 | 441 |
| 2011 | 1 | 482 |
Who submits
8 applicants cleared a MMI device since 2011. 96% of the clearances went to applicants in United States, then Japan (4%). By type: Traditional 96% and Special 4%.
| Applicant | Clearances since 2011 |
|---|---|
| Beckman Coulter, Inc. | 8 |
| Siemens Healthcare Diagnostics, Inc. | 5 |
| Abbott Laboratories Diagnostics Division | 3 |
| Abbott Point of Care, Inc. | 2 |
| Roche Diagnostics | 2 |
| Mitsubishi Chemical Medience CO | 1 |
| Ortho-Clinical Diagnostics, Inc. | 1 |
| Phc Corporation | 1 |
How FDA classifies it
Class II.
From 21 CFR 862.1215.
Standards
21 CFR 862.1215 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent MMI clearances declared.
Ask about MMI
Questions about MMI
What is FDA product code MMI?
Product code MMI, “Immunoassay Method, Troponin Subunit” in FDA's classification database, is a Class II device type under 21 CFR 862.1215 (creatine phosphokinase/creatine kinase or isoenzymes test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 95 clearances under MMI, 23 of them since 2011.
How many 510(k) clearances are there under MMI?
FDA’s 510(k) database listed 95 clearances under MMI as of Oct 29, 2026, 23 of them decided since 2011; the most recent decision was Jun 11, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a MMI 510(k)?
For the 5 MMI clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 266 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most MMI clearances?
Since 2011: Beckman Coulter, Inc. (8), Siemens Healthcare Diagnostics, Inc. (5), Abbott Laboratories Diagnostics Division (3), Abbott Point of Care, Inc. (2) and Roche Diagnostics (2). 8 applicants have cleared a MMI device in that time.